|
Visa & Mastercard Accepted
|
For Immediate
Professional Investigations call 1-800-820-7006
 Our
firm has performed research and represents many cases of
pharmaceutical error and defective drugs. One drug that
has captured our attention is Ketek. Ketek is the brand
name for the ketolide antibiotic, telithromycin, which
is used to treat mild to moderate respiratory
infections. Ketek has been under extensive investigation
by the FDA due the fact that clinical trials for this
drug are known to have been fraudulent. The
investigation team at Tim D. Wilson Investigations is
currently working with plaintiffs from across the United
States to ensure that justice is received for the many
injured victims of this defective drug.
The FDA has been highly criticized for the approval of
Ketek. In 2001 and 2003 Ketek was turned down by the
FDA, due to the fact that Aventis could not offer enough
evidence to prove their drug was safe. In 2004 Ketek was
finally approved by the FDA for the treatment of many
conditions such as respiratory tract infections,
sinusitis, bronchitis, and even types of pneumonia.
One of the most negative and harmful side effects of
Ketek are liver problems. In 2007 the FDA instructed
Sanofi-Aventis to put a warning on the label of Ketek
concerning the serious side effects which include liver
failure. Also a Public Health Advisory was issued in
2006 concerning the acute liver problems associated with
people who have used Ketek.
Through research and investigation our firm is currently
working with top physicians and attorneys from across
the country who recognize the evidence which suggests
that Sanofi-Aventis and the FDA had prior knowledge that
Ketek caused serious liver problems and even liver
failure. Our firm has become aware that the
Sanofi-Aventis and the FDA knew of these serious side
effects long before the issuance of the Public Health
Advisory. Data from a 2003 advisory committee has
suggested that in addition to liver failure and death,
Ketek has also been linked to heart and eye toxicity.
In April of 2008 an analysis that was performed using
information from the FDA linked approximately 18 deaths
and 134 cases of serious liver damage to the use of this
defective drug. Other people who have used Ketek have
also suffered from blurred vision, palpitations, and
rashes.
It is only right that the FDA be criticized for allowing
Ketek to pass the inspections. There has been well
documented proof that the clinical trials for Ketek were
fraudulent, but the FDA approved this defective drug
knowing that this occurred and serious side effects were
possible. Here at Tim D. Wilson investigations we
believe the FDA and Sanofi-Aventis should be held liable
for the many injuries that have been reported by use of
this defective drug. If you or a loved one has suffered
injuries from the use of Ketek, please contact our
office so that we may assist you in your case.
Other Pharmaceutical
Investigations / Research:
Call Info:
800-820-7006 | Toll Free
713-956-1111 | Local
TimWilsonInvestigations.com |
